How Long Does Semaglutide Stay in Your System?

About five weeks.

That is not an estimate from a blog. It is in the FDA-approved label, section 12.3 of the Ozempic prescribing information revised May 2026: “With an elimination half-life of approximately 1 week, semaglutide will be present in the circulation for about 5 weeks after the last dose” [1].

This article unpacks what that means in practice - why the number is what it is, what it means for starting, stopping, side effects, surgery and pregnancy planning, and what a five-week tail actually feels like.

This is information, not medical advice. Starting, stopping, pausing or changing any medicine is a decision to make with a healthcare provider.

What is semaglutide’s half-life?

Approximately one week. In published pharmacokinetic work the figure usually cited is about 165 hours [5].

A half-life is the time it takes for the amount of drug in your body to fall by half. Most drugs are considered essentially cleared after about five half-lives. Five times one week is five weeks - which is exactly what the label says [1].

For comparison:

Drug	Half-life	Rough time to clear
Native GLP-1 (your own hormone)	under 2 minutes	minutes
Liraglutide (Victoza, Saxenda)	13 to 15 hours [5]	about 3 days
Tirzepatide (Mounjaro, Zepbound)	about 5 days	about 3 to 4 weeks
Semaglutide (Ozempic, Wegovy, Rybelsus)	about 1 week [2]	about 5 weeks

Semaglutide’s half-life is roughly 13 times longer than liraglutide’s [5]. That gap is the entire reason one is weekly and the other daily.

Why does it last so long?

Two engineered features do the work.

A fatty acid that binds albumin. Semaglutide carries an 18-carbon fatty diacid chain. In the bloodstream that chain sticks reversibly to albumin, the most abundant blood protein. The label states semaglutide is “extensively bound to plasma albumin (>99%)” [2]. Bound drug cannot be filtered by the kidney and is protected from enzymes. Only the small free fraction can act - and as it is used up, more releases from the albumin pool.

A modified amino acid that blocks DPP-4. The enzyme that destroys your own GLP-1 in about two minutes cannot grip semaglutide’s altered position-8 residue.

The supporting numbers from the label: apparent clearance about 0.05 L/h, volume of distribution about 12.5 L after injection, elimination by general proteolytic breakdown of the peptide backbone rather than by liver CYP enzymes, and only about 3% of the dose excreted unchanged in urine [1][2].

Does the pill clear faster than the shot?

No, and this surprises people.

Oral semaglutide is absorbed quite differently - it peaks about an hour after a dose rather than one to three days later, and only 0.4% to 2% of the swallowed dose gets in depending on the formulation [3]. But once absorbed, it is the identical molecule with the identical albumin binding. The label gives the same “approximately one week” half-life for the tablets, with an absolute clearance of about 0.04 L/hour and a volume of distribution of about 8 L [3].

So switching to a pill does not give you a faster exit.

How long does it take to start working?

The same arithmetic runs in reverse.

Steady state - the point where the amount entering your body each week equals the amount leaving - is reached after 4 to 5 weekly doses [2]. Before that, levels are still climbing.

But “working” depends on what you mean:

• Appetite changes are often noticed within the first weeks, sometimes within days of the first dose.
• Steady blood levels at any given dose take about a month.
• Reaching a maintenance dose takes longer still. The Wegovy injection label runs 0.25 mg for weeks 1-4, 0.5 mg for weeks 5-8, 1 mg for weeks 9-12, 1.7 mg for weeks 13-16, and maintenance from week 17 [12]. Wegovy tablets step up in 30-day blocks to 25 mg by day 91 [12].
• Weight loss curves in the trials kept descending for a year or more before flattening.

If you are four weeks in and wondering whether it is working, the honest answer from the pharmacology is that you are still near the beginning.

What happens in the five weeks after your last dose?

Blood levels fall by roughly half each week. In rough terms:

Time since last dose	Approximate drug remaining
1 week	about 50%
2 weeks	about 25%
3 weeks	about 12%
4 weeks	about 6%
5 weeks	about 3%

Those are illustrative figures derived from a one-week half-life, not measurements from any individual.

Practically, that means the effects fade on a slope rather than a cliff. Appetite tends to return gradually. Gastric emptying drifts back toward baseline over the same period. If you have type 2 diabetes, blood glucose typically rises again as levels fall - which is one reason stopping is a clinical decision rather than a personal one.

What happens to your weight when you stop?

The best data comes from the STEP 1 trial extension.

Participants who had taken semaglutide 2.4 mg plus a structured lifestyle program for 68 weeks were followed for a year after both the drug and the lifestyle program were withdrawn. On average they regained two-thirds of the weight they had lost, and cardiometabolic improvements largely reversed alongside it [6].

Some detail worth keeping: those who stopped semaglutide regained 11.6 percentage points of their weight loss, against 1.9 percentage points in the placebo group, leaving net weight loss of 5.6% and 0.1% respectively at week 120.

The authors’ conclusion was that this “confirms the chronicity of obesity” and suggests ongoing treatment is needed to maintain the improvements [6]. Whether ongoing treatment makes sense for any individual is a conversation with a healthcare provider, not something to decide from a trial average.

It is worth being precise about what the extension tested: withdrawal of the medicine and the structured program at the same time. It is not a clean test of stopping the drug alone.

Why does the pregnancy rule say two months?

Because five weeks of drug plus a safety margin.

The label instructs discontinuing semaglutide at least 2 months before a planned pregnancy “because of the long half-life of semaglutide” [7]. Semaglutide is not recommended during pregnancy, and animal studies showed potential for fetal harm [7].

The two-month rule is not arbitrary caution. It is the five-week washout with room built in.

If you are taking semaglutide and planning a pregnancy, or become pregnant while taking it, that is an immediate conversation with a healthcare provider.

What about surgery, endoscopy or anesthesia?

This is where the long half-life becomes a practical safety issue rather than a curiosity.

Because semaglutide slows gastric emptying, food can still be in the stomach after a standard pre-procedure fast, which raises the risk of aspiration under anesthesia. The American Society of Anesthesiologists issued consensus-based preoperative guidance in June 2023, multi-society guidance followed in October 2024 [11], and a multidisciplinary consensus statement covering GLP-1, GIP and SGLT-2 agents was published in Anaesthesia in 2025 [10].

Two points from that guidance matter here.

First, gastrointestinal effects are most pronounced in the first weeks after starting or increasing a dose [10].

Second, and importantly: current recommendations cannot name a cessation period that guarantees gastric emptying has returned to baseline [10]. A five-week washout is not a protocol. Some clinicians now use gastric point-of-care ultrasound to check for residual stomach contents before airway management.

The action item is simple. Tell every member of your surgical, endoscopy, dental or anesthesia team that you take a GLP-1 medicine, well before the procedure. Do not decide a stop date yourself.

Does kidney or liver disease change the timeline?

Barely.

Semaglutide is broken down by general protein-chopping enzymes rather than filtered by the kidney or processed by liver CYP enzymes, so neither organ dominates its elimination.

Dedicated studies in people with mild, moderate and severe kidney impairment and end-stage renal disease found pharmacokinetics were not significantly affected, and no dose adjustment is warranted [8]. One analysis did find a longer mean half-life in severe renal impairment, around 221 hours, though values in end-stage renal disease were similar to normal function [8]. For oral semaglutide, day-10 half-life rose only from about 152 hours with normal kidney function to about 165 hours with severe impairment.

In hepatic impairment, exposure was comparable across liver-function groups and protein binding stayed above 99% [9].

The label reflects all of this: no dose adjustment for renal or hepatic impairment [2].

Can you speed up clearance?

No, and you should be skeptical of anything that claims otherwise.

Semaglutide’s slow exit is a direct result of albumin binding. There is no published method of unbinding it, flushing it or metabolizing it faster. Hydration, exercise, saunas and detox supplements do not change a peptide’s albumin affinity.

If you are having a difficult reaction, the response is to talk to a healthcare provider - not to look for a way to clear the drug.

What if you miss a dose?

The rule is different for each product, which is itself a reason to read your own label rather than a general article.

• Ozempic injection: the label says a missed dose can be taken as soon as possible within 5 days of the missed dose; if more than 5 days have passed, skip it and take the next dose on the regular day [1]. That five-day window exists precisely because of the long half-life - blood levels have not fallen far in that time.
• Wegovy injection: if the next scheduled dose is more than 2 days away, the label says to take the missed dose as soon as possible; if it is less than 2 days away, skip it. If two or more consecutive doses are missed, the label says to resume as scheduled or, if needed, restart the escalation schedule [12].
• Wegovy tablets: the label says to skip the missed dose and take the next one the following day [12].

Any question about your own schedule goes to your prescriber or pharmacist.

What is the short answer?

Semaglutide has a half-life of about one week and stays in your circulation for about five weeks after the last dose, according to the FDA label. It takes 4 to 5 weekly doses to reach steady levels, and roughly the same time to clear. That long tail is why the medicine works with weekly dosing, why side effects fade slowly, why the label says to stop two months before a planned pregnancy, and why your surgical team needs to know you are taking it.

Sources

1. Ozempic prescribing information, 2026 revision - FDA
2. Ozempic (semaglutide) injection label - DailyMed
3. Ozempic tablets and Rybelsus (oral semaglutide) label - DailyMed
4. Semaglutide - StatPearls, NCBI Bookshelf
5. STEP 8: Weekly semaglutide vs daily liraglutide - JAMA / PMC
6. Weight regain after withdrawal of semaglutide: the STEP 1 trial extension - Diabetes, Obesity and Metabolism
7. Wegovy (semaglutide) injection label, reproductive potential section - DailyMed
8. Pharmacokinetics of semaglutide in subjects with and without renal impairment - PMC
9. Pharmacokinetics and tolerability of semaglutide in people with hepatic impairment - PMC
10. Elective peri-operative management of adults taking GLP-1 receptor agonists: multidisciplinary consensus statement - Anaesthesia
11. New Multi-Society GLP-1 Clinical Practice Guidance - American Society of Anesthesiologists
12. Wegovy (semaglutide) injection and tablets label - DailyMed